Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONWARDS 11: Insulin Icodec vs Insulin Glargine in Type 1 Diabetes
NCT07076199Phase 3Active, not recruiting
- Sponsor
- Novo Nordisk
- Start
- Aug 2025
- Primary completion
- Jan 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 8
01
Overview
A Phase 3 trial of insulin icodec in type 1 diabetes mellitus (T1D), sponsored by Novo Nordisk. Started Aug 2025; status: active, not recruiting.
02
Drugs
insulin icodec
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT07076199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07076199.